# Episode 265 | Dr. Malcolm Townes, Innovation Fund Manager at Washington University | Strategic Medtech Commercialization: Lessons from the Gap Fund

Page: https://stenobird.com/podcast/project-medtech-601743/episode-265-dr-malcolm-townes-innovation-fund-manager-at-washington-university-strategic-medtech-commercialization-lessons-from-the-gap-fund
Text version: https://stenobird.com/podcast/project-medtech-601743/episode-265-dr-malcolm-townes-innovation-fund-manager-at-washington-university-strategic-medtech-commercialization-lessons-from-the-gap-fund.md
Podcast: [Project Medtech](https://stenobird.com/podcast/project-medtech-601743)
Published: 2026-06-15T05:00:00+00:00
Episode link: https://podcasters.spotify.com/pod/show/projectmedtech/episodes/Episode-265--Dr--Malcolm-Townes--Innovation-Fund-Manager-at-Washington-University--Strategic-Medtech-Commercialization-Lessons-from-the-Gap-Fund-e3ka6n9
Audio file: https://anchor.fm/s/1e555244/podcast/play/120969385/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-5-3%2F425461206-44100-2-3cebe81afb6cd.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/project-medtech-601743/episodes/episode-265-dr-malcolm-townes-innovation-fund-manager-at-washington-university-strategic-medtech-commercialization-lessons-from-the-gap-fund
Duration seconds: 2742

## Resource

In this episode, Dr. Malcolm Townes breaks down how WashU is building a more execution-focused commercialization engine through its Gap Fund, designed to advance non-drug, non-therapeutic technologies by funding the technology (not startups) to avoid conflicts and drive sharper development decisions. He shares why hands-on, milestone-based funding and rigorous customer discovery are essential to uncovering “unknown unknowns,” preventing expert blindness, and aligning products with real clinical workflows. The conversation also explores how WashU leverages EIRs and Venture Fellows to add commercialization horsepower, why “coachability” is the strongest predictor of success, and what innovators most often miss: FDA clearance isn’t enough—market access and reimbursement require different proof, data, and strategy. Dr. Malcolm Townes LinkedIn Washington University in St. Louis Gap Fund Website Duane Mancini LinkedIn Project Medtech Website Project Medtech LinkedIn Thank you to our sponsors: Ward Law and JumpStart Inc .

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/project-medtech-601743/episodes/episode-265-dr-malcolm-townes-innovation-fund-manager-at-washington-university-strategic-medtech-commercialization-lessons-from-the-gap-fund/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/project-medtech-601743/episode-265-dr-malcolm-townes-innovation-fund-manager-at-washington-university-strategic-medtech-commercialization-lessons-from-the-gap-fund.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.